References
- Babbitt B., Allen P. M., Matsueda G., Haber E., Unanue E. The binding of immunogenic peptides to la histocompatibility molecules. Nature 1985; 317: 359–362
- Chen B., Parham P. Direct binding of influenza peptides to class I HLA molecules. Nature 1989; 337: 743–746
- Rothbard J., Taylor W. A sequence pattern common to T cell epitopes. EMBO J. 1988; 7: 93–100
- Rothbard J., Lechler R., Howland K., Bal V., Eckels D., Sekaly R., Long E., Taylor W., Lamb J. Structural model of HLA-DR1 restricted T cell antigen recognition. Cell 1988; 52: 515–523
- Rothbard J., Pemberton R., Bodmer H., Askonas B. A., Taylor W. R. Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant. EMBO J. 1989; 8: 2321–2328
- Lorenz T., Tyler A., Allen P. Reconstruction of the immunogenetic peptide RNase (43–56) by identification and transfer of the critical residues into an unrelated backbone. J. Exp. Med. 1989; 170: 203–215
- Allen P., Matsueda G., Evans R., Dunbar J., Marshall G., Unanue E. Identification of the T cell and la contact residues of a T cell antigenic epitope. Nature 1987; 327: 713–716
- Sette A., Buus S., Colon S., Smith J., Miles C., Grey H. Structural characteristics of an antigen required for its interaction with la and recognition by T cells. Nature 1987; 328: 395–399
- Ogasawara K., Maloy W., Beverly B., Schwartz R. Functional analysis of the antigenic structure of a minor T cell determinant from pigeon cytochrome C. J. Immunol. 1989; 142: 1448–1458
- Rothbard J., Busch R., Howland K., Bal V., Fenton C., Taylor W., Lamb J. Structural analysis of a peptide-HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor. Internat. Immunol. 1990; 1: 479–486
- Lampson L. A., Levy R. Two populations of a la-like molecules on a human B cell line. J. Immunol. 1980; 125: 293–299
- Accolla R. Human B cell variants immunoselected against a single la antigen subset have lost expression of several la antigen subsets. J. Exp. Med. 1983; 157: 1053–1060
- Hume C., Accolla R., Lee J. Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes. Proc. Natl. Acad. Sci. USA 1987; 84: 8603–8607
- Hofmann K., Titus G., Montibeller J., Finn F. Avidin binding of carboxyl substituted biotin and analogues. Biochemistry 1982; 21: 978–988
- Busch R., Strang G., Howland K., Rothbard J. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Internat. Immunol., In press
- Rothbard J., Busch R., Bal V., Trousdale J., Lechler R., Lamb J. Reversal of HLA restriction by a point mutation in an antigenic peptide. Internat. Immunol. 1990; 1: 487–495